Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

Medicine and Dentistry

• Patient 100%
• Percutaneous Coronary Intervention 93%
• Ticagrelor 80%
• Placebo 46%
• Inpatient 33%
• Coronary Artery Disease 26%
• Acetylsalicylic Acid 26%
• Patient with Diabetes 20%
• Cardiovascular System 20%
• Death 20%
• Combination Therapy 13%
• Myocardial Infarction 13%
• Apoplexy 13%
• Major Bleeding 13%
• Intervention Trial 13%
• Diabetes Mellitus 6%
• Diabetes 6%
• Maturity Onset Diabetes of the Young 6%
• Health Outcomes 6%
• Follow up 6%
• Intervention Study 6%
• Coronary Artery 6%
• Group Therapy 6%
• Coronary Artery Bypass Graft 6%
• Bleeding 6%
• Stenosis 6%
• Chemotherapeutic Agent 6%
• Intention-to-Treat Analysis 6%
• Drug 6%
• Cause of Death 6%
• Antiplatelet 6%
• Cerebral Hemorrhage 6%
• Stenting 6%
• Indium 111 6%
• Voice 6%
• Therapeutic Procedure 6%
• Randomized Controlled Trial 6%